Content about Medical imaging

August 2, 2011
FDA gives new approval to Novartis MS drug

The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

EAST HANOVER, N.J. — The Food and Drug Administration has approved a new use for a drug made by Novartis for treating multiple sclerosis, the Swiss drug maker's U.S. subsidiary said Monday.

Novartis Pharmaceuticals announced the FDA's approval of Gilenya (fingolimod) for the reduction of T1 gadolinium-enhancing lesions, areas of inflammation in the central nervous system that mark disease activity in people with MS.

December 14, 2010
UMD professor named Maryland Chemist of the Year

A University of Maryland pharmacy professor won top honors last week for his work developing a means of measuring oxygen levels in the brain, the university said Monday.

BALTIMORE — A University of Maryland pharmacy professor won top honors last week for his work developing a means of measuring oxygen levels in the brain, the university said Monday.

The state chapter of the American Chemical Society named Gerald Rosen its Maryland Chemist of the Year. Rosen and colleagues are developing real-time electron paramagnetic resonance imaging, or EPRI, to measure critical oxygen levels in stroke and tumor patients and to improve drug development.

December 9, 2010
Medco study: Half of women 40 years and older don’t get annual mammograms

Despite recommendations, half of women ages 40 years and older do not get annual mammograms, according to a new study by pharmacy benefit manager Medco.

SAN ANTONIO — Despite recommendations, half of women ages 40 years and older do not get annual mammograms, according to a new study by pharmacy benefit manager Medco.

The analysis, from the Medco Research Institute, also found that nearly 40% of women ages 50 years and older don’t get biennial screenings. Data from the study will be presented at the 33rd annual CTRC-AACR San Antonio Breast Cancer Symposium.